Skip to main content
Caplight Logo









Resistia

Resistia

Private
DelawareHealthcare & Life Scienceshttps://resistia.bio

Last Round

Pre Seed

Oct 20, 2025

Total Funding Raised

$250,000

Company Overview

Resistia operates in Healthcare & Life Sciences and is based in Delaware. Its latest recorded funding round was a Pre Seed round in October 2025.

Resistia is a biotechnology company developing bio-therapies based on microbiota compounds to target resistant biofilm-related infections.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Resistia Comparables

Compare Resistia with similar companies based on industry and business-model similarity.

Resistia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BioTryp Therapeutics
87%
Disperazol Pharma ApS
82%
ProclaRx LLC
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Resistia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedOct 20, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Ignacio Massone

Co-founder & CEO

Founding Team

For institutional investors. Book with your work email.

Resistia Investors

Notable investors and investment history

Resistia investors
InvestorRounds
GRIDXPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 20, 2025

    $250K round led by GRIDX

Book a demo to see all signals

For institutional investors. Book with your work email.

Resistia Filings

Explore SEC and related filing metadata, where available.

Resistia filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Resistia's valuation, stock price, and market status.

Is Resistia a public or private company?

Resistia is a private company.

What is the current stock price of Resistia?

Resistia is a private company, so its shares have no public market price. Caplight tracks Resistia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Resistia worth (valuation)?

Valuation information for Resistia is not publicly available.

Can I buy Resistia stock?

Resistia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Resistia's last funding round?

Resistia's most recent funding round was Pre Seed on October 20, 2025.

Who are the main investors in Resistia?

Key investors in Resistia include GRIDX.

Will Resistia IPO soon?

No public IPO plans have been announced for Resistia.

How can I track Resistia secondary market activity?

Caplight tracks bids, offers, and trades in Resistia's shares on secondary markets.

Firmographic Details

HeadquartersDelaware
Employee Range4
Year FoundedN/A
Last FundingOct 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?